10/09/2026
Response Biomedical Corp. is pleased to announce the appointment of Taso Tsonis, CPA, CA as Chief Executive Officer, reinforcing our commitment to growth, innovation, and delivering excellence in diagnostics when answers matter most.
Since stepping into the interim CEO role in January 2025, Taso has provided strong leadership and helped guide Response Biomedical through an exciting period of growth and change.
During this time, we’ve reached important milestones, including the launch of RAMP® Xpress and continued expansion of our global network.
As we look ahead, Taso will continue to lead our team as we build on this momentum and pursue our long-term goals.
We’re excited for what’s ahead and look forward to continuing this journey together with our employees, partners, and customers.